`
`________________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`
`
`LUPIN LTD. AND LUPIN PHARMACEUTICALS INC.,
`
`Petitioner
`
`v.
`
`HORIZON THERAPEUTICS, INC.,
`
`Patent Owner
`
`________________
`
`Case IPR 2016-00829
`
`Patent 9,095,559
`
`________________
`
`NOTICE OF DEPOSITION OF KEITH VAUX, M.D.
`
`
`
`Case No. IPR2016-00829
`U.S. Patent No. 9,095,559
`
`Pursuant to 37 C.F.R. § 42.53, Patent Owner Horizon Therapeutics, Inc.
`
`(“Horizon”) hereby provides notice that it will examine Keith Vaux, M.D. a
`
`witness of Petitioner, Lupin Ltd. and Lupin Pharmaceuticals Inc. As agreed to by
`
`the parties, the examination will take place on January 31, 2017 at Goodwin
`
`Procter LLP, 620 Eighth Avenue, New York, NY 10018. The examination will
`
`begin at 9:00 am.
`
`The examination will take place before a Notary Public or other officer
`
`authorized by law to administer oaths, to be arrange for by counsel for Petitioner.
`
`The examination will be recorded using stenographic means.
`
`
`
`Dated: January 13, 2017
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`/Maureen D. Queler/
`By:
`Maureen D. Queler, Reg. No. 61,879
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`(202) 408-4000
`Counsel for Patent Owner in
`IPR2016-00829
`
`
`
`1
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing NOTICE OF
`
`DEPOSITION OF KEITH VAUX, M.D. was served electronically via e-mail on
`
`January 13, 2017, in its entirety on the following:
`
`Elizabeth J. Holland: eholland@goodwinprocter.com
`Cynthia Lambert Hardman: chardman@goodwinprocter.com
`
`Petitioner has agreed to electronic service.
`
`
`Dated: January 13, 2017
`
`
`
`
`
`/Maureen D. Queler/
`By:
`Maureen D. Queler, Reg. No. 61,879
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`
`
`
`
`
`